Table of Content

Introduction
Global Markets Direct Report Coverage
Transforming Growth Factor Beta 1 (TGFB1) - Overview
Transforming Growth Factor Beta 1 (TGFB1) - Therapeutics Development
Products under Development by Stage of Development
Products under Development by Therapy Area
Products under Development by Indication
Products under Development by Companies
Products under Development by Universities/Institutes
Transforming Growth Factor Beta 1 (TGFB1) - Therapeutics Assessment
Assessment by Mechanism of Action
Assessment by Route of Administration
Assessment by Molecule Type
Transforming Growth Factor Beta 1 (TGFB1) - Companies Involved in Therapeutics Development
Transforming Growth Factor Beta 1 (TGFB1) - Drug Profiles
Transforming Growth Factor Beta 1 (TGFB1) - Dormant Products
Transforming Growth Factor Beta 1 (TGFB1) - Discontinued Products
Transforming Growth Factor Beta 1 (TGFB1) - Product Development Milestones
Featured News & Press Releases
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer



List of Figures

List of Figures
Number of Products under Development by Stage of Development, 2022
Number of Products under Development by Therapy Areas, 2022
Number of Products under Development by Top 10 Indications, 2022
Number of Products by Mechanism of Actions, 2022
Number of Products by Routes of Administration, 2022
Number of Products by Stage and Routes of Administration, 2022
Number of Products by Molecule Types, 2022
Number of Products by Stage and Molecule Types, 2022

List of Tables

List of Tables
Number of Products under Development by Stage of Development, 2022
Number of Products under Development by Therapy Areas, 2022
Number of Products under Development by Indications, 2022
Number of Products under Development by Indications, 2022 (Contd..1)
Number of Products under Development by Indications, 2022 (Contd..2)
Number of Products under Development by Companies, 2022
Products under Development by Companies, 2022
Products under Development by Companies, 2022 (Contd..1)
Products under Development by Companies, 2022 (Contd..2)
Products under Development by Companies, 2022 (Contd..3)
Products under Development by Companies, 2022 (Contd..4)
Products under Development by Companies, 2022 (Contd..5)
Products under Development by Companies, 2022 (Contd..6)
Number of Products under Investigation by Universities/Institutes, 2022
Products under Investigation by Universities/Institutes, 2022
Number of Products by Stage and Mechanism of Actions, 2022
Number of Products by Stage and Route of Administration, 2022
Number of Products by Stage and Molecule Type, 2022
Pipeline by AiViva BioPharma Inc, 2022
Pipeline by AskGene Pharma Inc, 2022
Pipeline by Avellino Lab USA Inc, 2022
Pipeline by Bonac Corp, 2022
Pipeline by Bristol-Myers Squibb Co, 2022
Pipeline by Certa Therapeutics Pty Ltd, 2022
Pipeline by Chengdu Huitai Biomedicine Co Ltd, 2022
Pipeline by Chugai Pharmaceutical Co Ltd, 2022
Pipeline by Ensol Biosciences Inc, 2022
Pipeline by Genoscience Pharma, 2022
Pipeline by Genzyme Corp, 2022
Pipeline by Guangzhou Nanxin Pharmaceutical Co Ltd, 2022
Pipeline by HitGen Inc, 2022
Pipeline by Isarna Therapeutics GmbH, 2022
Pipeline by Johnson & Johnson, 2022
Pipeline by Lepu Biopharma Co Ltd, 2022
Pipeline by Nanjing Shenghe Pharmaceutical Co Ltd, 2022
Pipeline by Novartis AG, 2022
Pipeline by Phio Pharmaceuticals Corp, 2022
Pipeline by Scholar Rock Inc, 2022
Pipeline by Sirnaomics Inc, 2022
Pipeline by Sisaf Ltd, 2022
Dormant Products, 2022
Dormant Products, 2022 (Contd..1)
Dormant Products, 2022 (Contd..2)
Discontinued Products, 2022